Delaware 152nd General Assembly (2023-2024) Status: In Committee Bipartisan · 7 D · 1 R cosponsors

SB 332 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO A WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM.

Last action — Introduced and Assigned to Executive Committee in Senate

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 152nd General Assembly (2023-2024). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

This Act requires the Department of Health and Social Services, in consultation with persons interested in the sale and pricing of prescription drugs as well as interested federal and state officials and agencies, to design and implement a wholesale prescription drug importation program for the benefit of, and that generates savings for, Delaware residents. The Act establishes requirements for the program including all of the following: (1) The Department must become or contract with a state wholesaler and seek federal certification and approval to import eligible prescription drugs. (2) The program must comply with federal regulations and import from Canadian suppliers only those eligible prescription drugs that do not violate patent laws, that are not controlled substances, and for which importation creates substantial cost savings. (3) The Department must ensure that eligible prescription drugs imported under the program are not distributed, dispensed, or sold outside of Delaware. (4) Before submitting the proposed program to the federal government for certification, the Department must submit the proposal to the General Assembly. (5) The program must have an audit procedure to ensure compliance with the Act’s requirements and requires submission of an annual report to the General Assembly to track the program’s progress.

Bill Text

Action History

  1. Introduced and Assigned to Executive Committee in Senate

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

11 sponsors · 0 co-sponsors · 51 not signed on

Sponsors (11)

Co-sponsors (0)

None.

Not signed on (51)

51 members have not signed on to this bill.

Show all 51 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 332 do?
This Act requires the Department of Health and Social Services, in consultation with persons interested in the sale and pricing of prescription drugs as well as interested federal and state officials and agencies, to design and implement a wholesale prescription drug importation program for the benefit of, and that generates savings for, Delaware residents. The Act establishes requirements for the program including all of the following: (1) The Department must become or contract with a state wholesaler and seek federal certification and approval to import eligible prescription drugs. (2) The program must comply with federal regulations and import from Canadian suppliers only those eligible prescription drugs that do not violate patent laws, that are not controlled substances, and for which importation creates substantial cost savings. (3) The Department must ensure that eligible prescription drugs imported under the program are not distributed, dispensed, or sold outside of Delaware. (4) Before submitting the proposed program to the federal government for certification, the Department must submit the proposal to the General Assembly. (5) The program must have an audit procedure to ensure compliance with the Act’s requirements and requires submission of an annual report to the General Assembly to track the program’s progress.
Who sponsors SB 332?
SB 332 is sponsored by Madinah Wilson-Anton (Democratic), Brian Pettyjohn (Republican), Edward S. Osienski (Democratic), Eric Morrison (Democratic), Kendra Johnson (Democratic), John "Jack" Walsh (Democratic), Russell Huxtable (Democratic), David P. Sokola (Democratic), Paul S. Baumbach, Sean Matthews, and Peter C. Schwartzkopf.
What is the current status of SB 332?
This bill died with 152nd General Assembly (2023-2024). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 332?
Track SB 332 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 332

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 332

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →